✦ LIBER ✦

Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States

✍ Scribed by Won Chan Lee; Christopher Conner; Mette Hammer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of liraglutide versus

✍ Lee, W.C.; Conner, C.; Hammer, M. 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 311 KB

PDB27 Projected Cost-Effectiveness of Ex

✍ Wilson, B.P.; Beaudet, A.; Caputo, J.; Timlin, L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Estimating the Long-Term Cost-Effectiven

✍ Michael E. Minshall; Alan K. Oglesby; Matthew E. Wintle; William J. Valentine; S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

Long-term clinical and economic outcomes

✍ Lee, Won Chan; Samyshkin, Yevgeniy; Langer, Jakob; Palmer, James L. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 279 KB

PDB36 LONG-TERM COST-CONSEQUENCE ANALYSI

✍ Gaebler J Aledort; Y Samyshkin; ALG Guillermin; A Lloyd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PDB27 COST-EFFECTIVENESS OF EXENATIDE VE

✍ D Bruhn; S Malhan; S Kavuncubasi; J Smith-Palmer; V Reed 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB